Cynthia was President and CEO of the North American divisions of the global pharmaceutical companies Ipsen and Eisai, and also held leadership positions at Amgen and Johnson & Johnson. For nearly a decade she served on the Women’s Leadership Advisory Board at Harvard University’s Kennedy School of Government.
Cynthia holds a BSN from the University of Delaware and EMBA from Wharton at the University of Pennsylvania.
Cynthia is a Non-executive Director of Caladrius Biosciences Inc., Kadmon Group, and G1 Therapeutics Inc., where she chairs the Compensation Committee. She is also a member of an angel investment group associated with the University of North Carolina.